In August, OCRA hosted a listening session with the U.S. Food and Drug Administration (FDA) to better understand the impact of Covid-19 on clinical trial participation.
Watch the full FDA listening session in the video below.
Related Topics
The Overview: August 2026
September is Ovarian and Gynecologic Cancer Awareness Month—a time for our community to unite, raise awareness, and push forward in the search for better treatments and cures. This year, that push forward took a major step. In May, we launched the Research Exchange, a new kind of online community that represents a fundamental shift in how … Continued
Pedaling Toward a Cure
A New Milestone, Six Years in the Making For the past six years, Susan Fuhs of Virginia Beach has turned her own ovarian cancer diagnosis into an annual invitation for others to get involved, get educated, and give back. Susan is the longtime organizer behind the Fitness & Fight fundraising event in Virginia Beach—an event … Continued
OCRA’s Advocate’s Corner: August 2026
Written by Julia Thayer, OCRA’s Associate Director, Advocacy Advocacy Works. And We Need Your Voice. Every day, people impacted by gynecologic cancers are using their voices to create change, and OCRA’s Advocate Leaders are at the heart of that work. This past year, our Advocate Leaders have shown just how powerful advocacy can be: These numbers … Continued